Carl Zeiss Meditec AG
- Country
- 🇩🇪Germany
- Ownership
- Public, Subsidiary
- Established
- 2002-01-01
- Employees
- 4.8K
- Market Cap
- -
- Website
- http://www.zeiss.de
Clinical Trials
55
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (41 trials with phase data)• Click on a phase to view related trials
EDF IOL Versus Monofocal IOL
- Conditions
- Cataract Senile
- First Posted Date
- 2025-07-29
- Last Posted Date
- 2025-07-29
- Lead Sponsor
- Carl Zeiss Meditec AG
- Target Recruit Count
- 220
- Registration Number
- NCT07092020
- Locations
- 🇧🇬
Eye Hospital Zora, Sofia, Bulgaria
🇧🇬Specialized Ophthalmological Hospital for Active Treatment, Sofia, Bulgaria
🇧🇬Medical Center "Vereya", Stara Zagora, Bulgaria
Evaluation of Cataract Surgery Outcomes in Patients With Prior Laser Vision Correction Implanted With the CT LUCIA Lens
- Conditions
- Postoperative Visual Outcomes Following Cataract Surgery in Patients With Prior Myopic Corneal Laser Vision Correction
- First Posted Date
- 2025-07-24
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- Carl Zeiss Meditec AG
- Target Recruit Count
- 30
- Registration Number
- NCT07084545
- Locations
- 🇺🇸
Berkeley Eye Center, Sugar Land, Texas, United States
🇺🇸Piedmont Eye Center, Lynchburg, Virginia, United States
Evaluation of Refractive Outcomes in Patients Undergoing PRESBYOND Using the MEL90 Excimer Laser
- Conditions
- Presbyopia
- First Posted Date
- 2025-05-07
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Carl Zeiss Meditec AG
- Target Recruit Count
- 75
- Registration Number
- NCT06960785
- Locations
- 🇦🇺
Eye Laser Specialists, Melbourne, VIC/Australia, Australia
🇦🇺Crystal Eye and laser Center, Craigie, Western Australia, Australia
🇳🇿The Wellington Eye Centre, Wellington, New Zealand
Evaluation of a Monofocal Intraocular Lens
- Conditions
- Cataract
- First Posted Date
- 2024-05-24
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- Carl Zeiss Meditec AG
- Target Recruit Count
- 44
- Registration Number
- NCT06428955
- Locations
- 🇺🇸
Price Vision Group, Indianapolis, Indiana, United States
🇺🇸Huffman & Huffman PSC, Lexington, Kentucky, United States
🇺🇸The Pennsylvania State University and Penn State Health, Hershey, Pennsylvania, United States
Study to Confirm Safety and Performance of a New Multifocal IOL
- Conditions
- Cataract Senile
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Carl Zeiss Meditec AG
- Target Recruit Count
- 135
- Registration Number
- NCT06247683
- Locations
- 🇨🇿
Nemocnice Havlíčkův, Havlíčkův Brod, Czechia
🇨🇿Oční Centrum Praha, Prague, Czechia
🇨🇿Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha, Prague, Czechia
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
News
ZEISS Receives CE Mark Approval for AI-Powered CIRRUS PathFinder OCT Assessment Tool
ZEISS Medical Technology announced CE mark approval for CIRRUS PathFinder, an AI-powered clinical support tool that uses deep learning algorithms to automatically identify abnormal macular OCT B-scans.
ZEISS CLARUS 700 Ultra-Widefield Retinal Imaging System Receives NMPA Approval in China
ZEISS Medical Technology announced that its CLARUS 700 ultra-widefield fundus imaging camera has received National Medical Products Administration (NMPA) approval in China, expanding access to advanced retinal diagnostic capabilities.
ZEISS Medical Technology's ILM-Blue Receives NMPA Approval in China, Expanding Surgical Options for Retinal Surgeons
ILM-Blue, a vital staining dye used in vitreoretinal surgery, has received NMPA approval in China, becoming the first DORC posterior dye product available in the Chinese market.
ZEISS VISUMAX 800 with SMILE Pro Receives NMPA Approval for Laser Vision Correction in China
ZEISS Medical Technology has secured NMPA approval in China for the VISUMAX 800 with SMILE pro software, designed to treat nearsightedness with or without astigmatism.